Low turnover osteoporosis in sheep induced by hypothalamic-pituitary disconnection

Journal of Orthopaedic Research

Volumn 30, Issue 8, 2012, Pages 1254-1262

  Beil, Frank Timo ^a   Oheim, Ralf ^a   Barvencik, Florian ^a   Hissnauer, Tim N ^a   Pestka, Jan M ^a   Ignatius, Anita ^b   Rueger, Johannes M ^a   Schinke, Thorsten ^a   Clarke, Iain J ^c   Amling, Michael ^a   Pogoda, Pia ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c MONASH UNIVERSITY   (Australia)

Author keywords

central control; hypothalamic pituitary disconnection (HPD); large animal model; low turnover; osteoporosis

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE REMODELING; BONE TURNOVER; CONTROLLED STUDY; CORTICAL BONE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHALAMUS PITUITARY DISCONNECTION; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; OVARIECTOMY; PHENOTYPE; PRIORITY JOURNAL; SHEEP;

ANIMALS; BONE REMODELING; DISEASE MODELS, ANIMAL; FEMALE; HYPOTHALAMUS; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS; PITUITARY GLAND; SHEEP, DOMESTIC;

EID: 84862757738     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22066     Document Type: Article

References (39)

1. Rodan GA, Martin TJ,. 2000. Therapeutic approaches to bone diseases. Science 289: 1508-1514.
2. Riggs BL, Melton LJ III., 1986. Involutional osteoporosis. N Engl J Med 314: 1676-1686.
3. Melton LJ III., 2003. Epidemiology worldwide. Endocrinol Metab Clin North Am 32: 1-13.
4. Harada S, Rodan GA,. 2003. Control of osteoblast function and regulation of bone mass. Nature 423: 349-355.
5. Rodan GA, Martin TJ,. 1981. Role of osteoblasts in hormonal control of bone resorption- A hypothesis. Calcif Tissue Int 33: 349-351.
6. Amling M, Takeda S, Karsenty G,. 2000. A neuro (endo)crine regulation of bone remodeling. BioEssays 22: 970-975.
7. Chien KR, Karsenty G,. 2005. Longevity and lineages: toward the integrative biology of degenerative diseases in heart, muscle, and bone. Cell 120: 533-544.
8. Ducy P, Amling M, Takeda S, et al. 2000. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100: 197-207.
9. Takeda S, Elefteriou F, Levasseur R, et al. 2002. Leptin regulates bone formation via the sympathetic nervous system. Cell 111: 305-317.
10. Elefteriou F, Ahn JD, Takeda S, et al. 2005. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434: 514-520.
11. Fu L, Patel MS, Bradley A, et al. 2005. The molecular clock mediates leptin-regulated bone formation. Cell 122: 803-815.
12. Thomas T,. 2003. Leptin: a potential mediator for protective effects of fat mass on bone tissue. Joint Bone Spine 70: 18-21.
13. Tamasi JA, Arey BJ, Bertolini DR, et al. 2003. Characterization of bone structure in leptin receptor-deficient Zucker (fa/fa) rats. J Bone Miner Res 18: 1605-1611.
14. Foldes J, Shih MS, Levy J,. 1992. Bone structure and calcium metabolism in obese Zucker rats. Int J Obes Relat Metab Disord 16: 95-102.
15. Mathey J, Horcajada-Molteni MN, Chanteranne B, et al. 2002. Bone mass in obese diabetic Zucker rats: influence of treadmill running. Calcif Tissue Int 70: 305-311.
16. Martin A, de Vittoris R, David V, et al. 2005. Leptin modulates both resorption and formation while preventing disuse-induced bone loss in tail-suspended female rats. Endocrinology 146: 3652-3659.
17. Pogoda P, Egermann M, Schnell JC, et al. 2006. Leptin inhibits bone formation not only in rodents, but also in sheep. J Bone Miner Res 21: 1591-1599.
18. Thorndike EA, Turner AS,. 1998. In search of an animal model for postmenopausal diseases. Front Biosci 3: 17-26.
19. Turner AS,. 2002. The sheep as a model for osteoporosis in humans. Vet J 163: 232-239.
20. Eric G, Colman MD,. 2003. The Food and Drug Administration's Osteoporosis Guidance Document: past, present, and future. J Bone Miner Res 18: 1125-1128.
21. Reinwald S, Burr D,. 2008. Review of nonprimate, large animal models for osteoporosis research. J Bone Miner Res 23: 1353-1368.
22. Goodman RL,. 1994. Neuroendocrine control of the ovine estrous cycle. In:, Knobil E, Neill JD, editors. The physiology of reproduction, 2nd ed. New York: Raven Press. pp 659-709.
23. Newman E, Turner AS, Wark JD,. 1995. The potential of sheep for the study of osteopenia: current status and comparison with other animal models. Bone 16: 277-284.
24. Russell WM,. 1995. The development of the three Rs concept. Altern Lab Anim 23: 298-304.
25. Clarke IJ, Cummins JT, de Kretser DM,. 1983. Pituitary gland function after disconnection from direct hypothalamic influences in the sheep. Neuroendocrinology 36: 376-384.
26. Amling M, Priemel M, Holzmann T, et al. 1999. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 140: 4982-4987.
27. Parfitt AM, Drezner MK, Glorieux FH, et al. 1987. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2: 595-610.
28. Turner AI, Canny BJ, Hobbs RJ, et al. 2002. Influence of sex and gonadal status of sheep on cortisol secretion in response to ACTH and on cortisol and LH secretion in response to stress: importance of different stressors. Endocrinology 173: 113-122.
29. Trentz OA, Handschin AE, Bestmann L, et al. 2005. Influence of brain injury on early posttraumatic bone metabolism. Crit Care Med 33: 399-406.
30. Morley J, Marsh S, Drakoulakis E, et al. 2005. Does traumatic brain injury result in accelerated fracture healing? Injury 36: 363-368.
31. Rigaux P, Benabid N, Darriet D, et al. 2005. Study of serum factors potentially involved in the pathogenesis of heterotopic bone formation after severe brain injury. Joint Bone Spine 72: 146-149.
32. Sigrist IM, Gerhardt C, Alini M, et al. 2007. The long-term effects of ovariectomy on bone metabolism in sheep. J Bone Miner Metab 25: 28-35.
33. Lill CA, Gerlach UV, Eckhardt C, et al. 2002. Bone changes due to glucocorticoid application in an ovariectomized animal model for fracture treatment in osteoporosis. Osteoporos Int 13: 407-414.
34. Egermann M, Goldhahn J, Holz R, et al. 2008. A sheep model for fracture treatment in osteoporosis: benefits of the model versus animal welfare. Lab Anim 42: 453-464.
35. Pivonello R, Colao A, Di Somma C, et al. 1998. Impairment of bone status in patients with central diabetes insipidus. J Clin Endocrinol Metab 83: 2275-2280.
36. Wronski TJ, Cintrón M, Doherty AL, et al. 1988. Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 123: 681-686.
37. Corlett SC, Couch M, Care AD, et al. 1990. Measurement of plasma osteocalcin in sheep: assessment of circadian variation, the effect of age and nutritional status and the response to perturbation of the adrenocortical axis. Exp Physiol 75: 515-527.
38. Pastoureau P, Merle B, Delmas PD,. 1988. Specific radioimmunoassay for ovine bone gla-protein (osteocalcin). Acta Endocrinol (Copenh) 119: 152-160.
39. Pastoureau P, Meunier PJ, Delmas PD,. 1991. Serum osteocalcin (bone gla-protein), an index of bone growth in lambs. Comparison with age-related histomorphometric changes. Bone 12: 143-149.